Printer Friendly

AMRI appoints president for Europe.

M2 PHARMA-May 23, 2012-AMRI appoints president for Europe(C)2012 M2 COMMUNICATIONS

Contract research and manufacturing organisation AMRI on Wednesday announced that it has appointed Ian Shott as president of AMRI Europe.

In this newly created role Shott will report to Thomas D'Ambra, chairman, president and chief executive, of AMRI. In his new role Shott will have responsibility for AMRI's business operations in Europe, which includes the company's site in Wales, UK, and he will work closely with AMRI's European-based business development team.

Prior to his appointment as president of AMRI Europe Shott was the founder and chief executive of Excelsyn, now AMRI UK, which was acquired in February 2010 to expand the company's services platform and footprint in Europe.

Currently Shott serves as managing director of Shott Consulting Limited, where he provides consulting services to the healthcare and chemical industries, and leads industry boards for the British government in science, technology, innovation and business development.

((Comments on this story may be sent to>PDMay 23, 2012>JNM2 PHARMA.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:May 23, 2012
Previous Article:AbD Serotec to launch series of anti-drug antibodies.
Next Article:ETView Medical Ltd receives US FDA clearance of a 510(k) Pre-Marketing Notification Application for VivaSight DL Airways Management System.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters